New strategies to prevent mastitis.
Bovine mastitis remains as the disease causing the biggest economic losses to the dairy industry, despite the intensive research and prevention measures at herd level carried out for decades. Antibiotics are widely used to combat mastitis, but focus should be shifted from treatment to more economical and efficient prevention. The bacteriological aetiology of mastitis has changed from contagious to environmental pathogens, which has reduced the efficacy of the traditional mastitis control strategies. Considerable progress in the understanding of epidemiology, immunology, diagnostics and pathogenesis of mastitis has been made. The modern molecular biological methods offer good possibilities for the research of the epidemiological and virulence aspects of bacteria, which may help in building-up specific mastitis control strategies for dairy herds. Studies on the host response and relationship between somatic cell count and susceptibility to mastitis offer tools for genetic improvement of dairy cows. Biotechnological approaches for mastitis prevention are in the developmental stage, but many problems are associated, e.g. with vaccination of dairy cows against mastitis. Different methods of immunomodulation for the prevention of mastitis have shown promise in experimental trials, but the evidence is not yet enough to support commercial applications. Improving nutrition, housing and environment of dairy cattle are still crucial in the prevention of mastitis, especially during the most susceptible period after parturition. New milking techniques including robotic milking may provide better possibility for proper milking and improved udder health. Mastitis control should be part of the herd health programme in the dairy herds. In this paper, results from recent research and proposals for new prevention strategies in the field of mastitis are reviewed.
Pyörälä
S
S
Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, Saari Unit, Saarentaus, Finland. satu.pyoraia@helsinki.fi
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000822:Animal Husbandry / Q000379:methods; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002417:Cattle; D003612:Dairying / Q000379:methods; D005260:Female; D008414:Mastitis, Bovine / Q000276:immunology / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines